Skip to content

MBX Biosciences, Inc. MBX Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$13.63B-7.0%
Amgen logo
AmgenAMGN
$4.11B+26.2%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$1.22M+41.5%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$5.26M-55.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$62.91M+77.9%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$13.66M-2.6%

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$2.3B+475%
Enterprise value$2.26B+533%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MBX Biosciences, Inc.'s prepaid & other current?
MBX Biosciences, Inc. (MBX) reported prepaid & other current of $8.56M in Q1 2026.
How has MBX Biosciences, Inc.'s prepaid & other current changed year-over-year?
MBX Biosciences, Inc.'s prepaid & other current increased by 145.2% year-over-year, from $3.49M to $8.56M.
What is the long-term trend for MBX Biosciences, Inc.'s prepaid & other current?
Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s prepaid & other current has grown at a 67.6% compound annual growth rate (CAGR), from $2.79M to $7.83M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.